Product Name | MF | CAS | Details |
---|
4-(4-Bromo-3-[1,3]dioxolan-2-yl-phenoxy)-benzonitrile | C16H12BrNO3 | 1217366-74-9 | Details |
(1R,2S,3R,4R)-1-(4-Chloro-3-(4-ethoxybenzyl)phenyl)hexane-1,2,3,4,5,6-hexaol | C21H27ClO7 | Details |
lifitegrast impurity E | Details |
lifitegrast impurity J | Details |
2-Amino-5-methylbenzoic acid | C8H9NO2 | 2941-78-8 | Details |
Sildenafil intermediate | C17H19ClN4O4S | 139756-22-2 | Details |
Lorcaserin impurity C | Details |
4-(4-Bromo-3-formyl-phenoxy)-benzonitrile | C14H8BrNO2 | 906673-54-9 | Details |
4-[4-Bromo-3-(tetrahydro-pyran-2-yloxymethyl)-phenoxy]-benzonitrile | C19H18BrNO3 | 943311-78-2 | Details |
lifitegrast impurity B1 | Details |
lifitegrast impurity G | Details |
Lorcaserin impurity B | C11H15Cl2N | 953789-37-2 | Details |
4-(4-Bromo-3-hydroxymethyl-phenoxy)-benzonitrile | C14H10BrNO2 | 906673-45-8 | Details |
Vonoprazan | C17H16FN3O2S | 881681-00-1 | Details |
8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one | C24H31N7O2 | 1376615-91-6 | Details |
lifitegrast impurity A2 | Details |
lifitegrast impurity N | Details |
Flupirtine Maleate | C19H21FN4O6 | 75507-68-5 | Details |
lifitegrast impurity F | Details |
lifitegrast impurity K | Details |
2,3,5,6,7,8-HEXAHYDRO-1H-CYCLOPENTA[B]QUINOLIN-9-YLAMINE | C12H16N2 | 62732-44-9 | Details |
4-(2-FLUOROPHENYL)-1H-PYRROLE-3-CARBONITRILE | C11H7FN2 | 103418-03-7 | Details |
Vonoprazan impurity F | Details |
lifitegrast impurity C | C20H20Cl2N2O5S | 851785-70-1 | Details |
lifitegrast impurity H | Details |
Vonoprazan impurity M | Details |
Sildenafil N-oxide | C22H30N6O5S | 1094598-75-0 | Details |
Acotiamide Hydrochloride | C21H31ClN4O5S | 773092-05-0 | Details |
5-phenyl-1H-pyrrole-3-carbaldehyde | C11H9NO | 56448-22-7 | Details |
R-lifitegrast | Details |
2-Amino-1-cyclopentene-1-carbonitrile | C6H8N2 | 2941-23-3 | Details |
lifitegrast impurity A3 | Details |
lifitegrast impurity O | Details |
Lorcaserin | C11H14ClN | 616202-92-7 | Details |
AHU-377 | C24H29NO5 | 149709-62-6 | Details |
Lorcaserin Dechloro Impurity | Details |
(2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | C24H33ClO8 | 960404-48-2 | Details |
(2R,4S)-5-(biphenyl-4-yl)-4-(tert-butoxycarbonylamino)-2-methylpentanoic acid | C23H29NO4 | 1012341-50-2 | Details |
lifitegrast impurity A | Details |
lifitegrast impurity L | Details |
7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one | C15H18INO3 | 148870-57-9 | Details |
[(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]oxan-2-yl]methyl acetate | C29H33ClO10 | 461432-25-7 | Details |
Entresto | C48H58N6O8 | 936623-90-4 | Details |
lifitegrast impurity D | C39H35Cl2N3O10S2 | 2641788-18-1 | Details |
lifitegrast impurity I | Details |
Lorcaserin impurity A | Details |
Vonoprazan impurity | Details |
4-Bromo-3-[1,3]dioxolan-2-yl-phenol | C9H9BrO3 | 1160182-44-4 | Details |
lifitegrast impurity B | Details |
Sildenafil intermediate | C8H14N4O | 139756-22-1 | Details |
(2R,4s)-4-amino-5-(biphenyl-4-yl)-2-methylpentanoic acid ethyl ester hydrochloride | C20H26ClNO2 | 149690-12-0 | Details |
lifitegrast | C29H24Cl2N2O7S | 1025967-78-5 | Details |
lifitegrast impurity A1 | Details |
lifitegrast impurity M | Details |
Product Total: Product Page: | ||||
1 |